Works by Miyuki Yuasa


Results: 2
    1
    2

    Phase I study of OPB-51602, an oral inhibitor of signal transducer and activator of transcription 3, in patients with relapsed/refractory hematological malignancies.

    Published in:
    Cancer Science, 2015, v. 106, n. 7, p. 896, doi. 10.1111/cas.12683
    By:
    • Ogura, Michinori;
    • Uchida, Toshiki;
    • Terui, Yasuhito;
    • Hayakawa, Fumihiko;
    • Kobayashi, Yukio;
    • Taniwaki, Masafumi;
    • Takamatsu, Yasushi;
    • Naoe, Tomoki;
    • Tobinai, Kensei;
    • Munakata, Wataru;
    • Yamauchi, Takeshi;
    • Kageyama, Akiko;
    • Yuasa, Miyuki;
    • Motoyama, Masaaki;
    • Tsunoda, Takeshi;
    • Hatake, Kiyohiko
    Publication type:
    Article